BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26939700)

  • 21. Targeting eIF4E inhibits growth, survival and angiogenesis in retinoblastoma and enhances efficacy of chemotherapy.
    Wang G; Li Z; Li Z; Huang Y; Mao X; Xu C; Cui S
    Biomed Pharmacother; 2017 Dec; 96():750-756. PubMed ID: 29049978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual targeting of protein translation and nuclear protein export results in enhanced antimyeloma effects.
    Li S; Fu J; Walker CJ; Yang J; Bhutani D; Chakraborty R; Mamillapalli N; Mapara MY; Landesman Y; Lentzsch S
    Blood Adv; 2023 Jun; 7(12):2926-2937. PubMed ID: 36827679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.
    Attar-Schneider O; Drucker L; Zismanov V; Tartakover-Matalon S; Rashid G; Lishner M
    Lab Invest; 2012 Feb; 92(2):178-90. PubMed ID: 22083671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
    Liu Y; Sun L; Su X; Guo S
    Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells.
    Martin SK; Diamond P; Williams SA; To LB; Peet DJ; Fujii N; Gronthos S; Harris AL; Zannettino AC
    Haematologica; 2010 May; 95(5):776-84. PubMed ID: 20015878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
    Ko SY; Guo H; Barengo N; Naora H
    Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G.
    Moerke NJ; Aktas H; Chen H; Cantel S; Reibarkh MY; Fahmy A; Gross JD; Degterev A; Yuan J; Chorev M; Halperin JA; Wagner G
    Cell; 2007 Jan; 128(2):257-67. PubMed ID: 17254965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulation of the eIF4E signaling pathway contributes to the progression of gastric cancer, and targeting eIF4E by perifosine inhibits cell growth.
    Liang S; Guo R; Zhang Z; Liu D; Xu H; Xu Z; Wang X; Yang L
    Oncol Rep; 2013 Jun; 29(6):2422-30. PubMed ID: 23588929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
    Xu M; Tao Z; Wang S; Jiang Y; Qu M
    Biochem Biophys Res Commun; 2019 May; 512(4):902-907. PubMed ID: 30929914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis.
    Ruan H; Li X; Xu X; Leibowitz BJ; Tong J; Chen L; Ao L; Xing W; Luo J; Yu Y; Schoen RE; Sonenberg N; Lu X; Zhang L; Yu J
    Elife; 2020 Nov; 9():. PubMed ID: 33135632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of bromophenol-thiazolylhydrazone hybrids inhibiting the interaction of translation initiation factors eIF4E/eIF4G as multifunctional agents for cancer treatment.
    Wang L; Guo C; Li X; Yu X; Li X; Xu K; Jiang B; Jia X; Li C; Shi D
    Eur J Med Chem; 2019 Sep; 177():153-170. PubMed ID: 31132531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
    Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
    Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions.
    Alzrigat M; Párraga AA; Agarwal P; Zureigat H; Österborg A; Nahi H; Ma A; Jin J; Nilsson K; Öberg F; Kalushkova A; Jernberg-Wiklund H
    Oncotarget; 2017 Feb; 8(6):10213-10224. PubMed ID: 28052011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.
    Jacobson BA; Thumma SC; Jay-Dixon J; Patel MR; Dubear Kroening K; Kratzke MG; Etchison RG; Konicek BW; Graff JR; Kratzke RA
    PLoS One; 2013; 8(11):e81669. PubMed ID: 24260583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signalling to eIF4E in cancer.
    Siddiqui N; Sonenberg N
    Biochem Soc Trans; 2015 Oct; 43(5):763-72. PubMed ID: 26517881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. URI regulates tumorigenicity and chemotherapeutic resistance of multiple myeloma by modulating IL-6 transcription.
    Fan JL; Zhang J; Dong LW; Fu WJ; Du J; Shi HG; Jiang H; Ye F; Xi H; Zhang CY; Hou J; Wang HY
    Cell Death Dis; 2014 Mar; 5(3):e1126. PubMed ID: 24625985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K; Wang R; Wang X; Lin F; Shen JJ; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Feb; 113(3):443-56. PubMed ID: 18327707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
    Jakubikova J; Cervi D; Ooi M; Kim K; Nahar S; Klippel S; Cholujova D; Leiba M; Daley JF; Delmore J; Negri J; Blotta S; McMillin DW; Hideshima T; Richardson PG; Sedlak J; Anderson KC; Mitsiades CS
    Haematologica; 2011 Aug; 96(8):1170-9. PubMed ID: 21712538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
    Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
    PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of eIF4E signaling by ribavirin selectively targets lung cancer and angiogenesis.
    Tan H; He L; Cheng Z
    Biochem Biophys Res Commun; 2020 Aug; 529(3):519-525. PubMed ID: 32736668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.